Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

HepeX-B reduces viral load of patients with chronic HBV infection

Nov. 26, 2004

Merimepodib increases virological response to interferon plus ribavirin therapy in hepatitis C

Nov. 26, 2004

Novel agent by Microbia shows antinociceptive effects in animal models of visceral pain

Nov. 26, 2004

Coumarinolignoid composition for use as hepatoprotective agent described in patent

Nov. 26, 2004

First safety review completed for phase II study of HepeX-B

Nov. 26, 2004

Therapeutic benefits of the Enteryx(R) procedure in GERD

Nov. 25, 2004

Isatoribine reduces HCV viral load in patients with chronic hepatitis C

Nov. 25, 2004

New antioxidants in early development at Japan Science and Technology

Nov. 25, 2004

Cilansetron improves quality of life of patients with diarrhea-predominant IBS

Nov. 24, 2004

New Roche study investigates response rates to HCV therapy in Latinos

Nov. 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...